Gene mutation accelerates tumour growth in colorectal cancer
A common gene mutation could be the cause of tumours forming in colorectal cancer patients, a new study suggests.
A team of researchers from ChristianaCare and the University of Delaware uncovered how a common genetic mutation in colorectal cancer disrupts the colon’s normal tissue renewal process, causing immature cells to build up, tissue structure to break down and early tumours to form.
The lining of the colon constantly renews itself but the process of tissues being shed and replaced depends on a steady cycle. New cells form at the base of tiny pockets called crypts, mature as they move upward, and are eventually shed.
The new study, published in Cancers, shows how this natural process breaks down when a mutation occurs in a gene called APC, which is altered in about 90% of colorectal cancers. Rather than speeding up cell growth, the APC mutation creates a slowdown, or bottleneck, in the colon tissue’s renewal cycle.
Colorectal cancer is one of the most common and deadly cancers worldwide. According to the World Health Organization, more than 1.9 million people are diagnosed each year, and about 930,000 people die from the disease annually.
“This finding changes how we think about the very first steps of colon cancer,” said Bruce Boman, senior author of the study and Senior Researcher at the Cawley Center for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & Research Institute.
“Instead of cancer starting because cells grow too fast, we found that it may start because the normal tissue renewal process slows down, creating a backup of cells that should have moved on. That backup sets the stage for tumours to grow.”
Findings offer route to treatment
In the study into colorectal cancer, researchers studied patient tissue and used a computer model that shows how colon cells normally grow and renew. When they slowed this renewal process in the model, it matched what they saw in tissue with the APC mutation. Cells became crowded, the structures lost their normal shape, and early tumour-like growths, known as adenomas, began to form.
“Our findings show that APC mutation does more than turn on growth signals,” Boman said. “It changes the timing of renewal. Once that timing is off, the tissue becomes vulnerable to structural damage and early tumour growth.”
The findings also point toward a potential new approach to treatment. The researchers found evidence that the disrupted renewal process may trigger a chain reaction that allows pre-cancerous cells to keep copying themselves, fuelling tumour growth.
By targeting this process, it may be possible to restore normal renewal timing and healthier tissue structure before cancer becomes established.
“This study shows that cancer isn’t just about rogue cells, but about a system that’s fallen out of rhythm,” Boman added.
“If we can reset that renewal process, we may be able to prevent or slow early tumour growth before it gains momentum.”
Bruno Quinney, Content Team, DDW
